Weeks after being named head of CDER, Pazdur has submitted paperwork to step down at the end of the month, exacerbating ...

Food and Drug Administration chief Marty Makary convinced Rick Pazdur to take the role to help bring stability to the roiling ...

The US Food and Drug Administration’s longtime oncology chief has filed to retire from the agency just weeks after he was ...

Kirk Milhoan has claimed without evidence that the covid-19 shots caused spikes in cancer and miscarriages. Now he's helping ...

A confidential internal memo from the U.S. Food and Drug Administration (FDA) is creating new controversy around vaccine ...

The three-dose hepatitis B vaccine has a long track record of safety, but rolling back recommendations could leave kids ...

Richard Pazdur, the US Food and Drug Administration’s lead drug regulator, plans to retire from the agency only weeks after ...

Concern about that link, particularly relating to teenage boys and young men, has been a key argument against administering ...

With no evidence to support the claim that 10 children died due to COVID-19 vaccines, experts unpack the impact of CBER chief ...

The U.S. Food and Drug Administration's newly appointed head of the drug evaluation department, Richard Pazdur, is set to ...

FDA moves reshaping drug policy include fast-track programs, updated biosimilar guidance, and new rare disease approval pathways.